mTOR Signaling and Cancer Progression
mTOR Signaling and Cancer Progression
The Tumor Microenvironment
The Tumor Microenvironment
PI3K/mTOR/AKT Signaling Pathway
Tumor Immunotherapy
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 21, 2026

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
Published on: April 30, 2021
Greg M Delgoffe1, Jonathan D Powell
1Sidney-Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.
The mammalian target of rapamycin (mTOR) integrates immune signals to regulate metabolism and cell survival. This kinase is crucial for adaptive immunity, influencing dendritic cell activation and T cell responses.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: